A medical professional explores the management of bronchiectasis exacerbations, detailing the significance of sputum color, the potential for hemoptysis, and the exacerbation of comorbidities such as COPD and asthma.
The hesitation of the National Institute for Health and Care Excellence (NICE) in sanctioning a “miracle” drug for Cystic Fibrosis, as recently reported in this paper, might seem harsh and unfair. Still the watchdog’s decision is certainly illustrative of an ever more pressing problem – the NHS simply can’t afford to pay the inflated prices charged by pharmaceutical companies for new medicines.
The study’s investigators suggest the results in this patient population may indicate rises in clinically diagnosed viral infections from viruses other than SARS-CoV-2 following pandemic lockdown changes.
Two posters presented at the CHEST Annual Meeting 2023 showed how real-world exacerbation rates in asthma and chronic obstructive pulmonary disease (COPD) dropped after patients started using a single inhaler that delivers triple therapy.